Azedra Designated as Breakthrough Therapy for Iobenguane-Avid Metastatic or Recurrent Pheochromocytoma and Paraganglioma, Received Orphan Drug And Fast Track Designations From FDA
July 28, 2015 at 08:33 AM EDT
Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX), an oncology company developing innovative ways to target and treat cancer, announced ...
